By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Pulsatilla nigricans

Sound forms: Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs ⓘ Learn more

Performance statistics based

X
 
  • 154
    Diseases: E 37%, I 12%, 591 case. 1802 meds
    • 7
      Chest: E 53%, I 12%, 152 cases. 957 meds
      • 14
        Abdomen: E 46%, I 12%, 231 case. 1011 meds
        • 4
          Pelvis: E 59%, I 12%, 39 cases. 423 meds
          • 8
            Back: E 45%, I 11%, 140 cases. 818 meds
            • 17
              Limbs: E 36%, I 11%, 421 case. 889 meds
              • 5
                Cardiovascular system: E 40%, I 9%, 280 cases. 1060 meds
                • 9
                  Bone system: E 40%, I 9%, 260 cases. 235 meds
                  • 42
                    Common symptoms: E 33%, I 9%, 26 cases. 693 meds
                    • 12
                      Respiratory system: E 42%, I 8%, 515 cases. 936 meds
                      • 17
                        Psyche: E 25%, I 7%, 760 cases. 1247 meds
                        • 16
                          Digestive system: E 31%, I 7%, 665 cases. 1228 meds
                          • 17
                            Head: E 34%, I 6%, 693 cases. 1187 meds
                            • 23
                              Skin: E 32%, I 6%, 544 cases. 1190 meds
                              • 13
                                The muscular system: E 38%, I 5%, 116 cases. 208 meds
                                • 8
                                  Down neck: E 27%, I 4%, 145 cases. 685 meds
                                  • 8
                                    Anamnesis: E 28%, I 4%, 223 cases. 640 meds
                                    • 6
                                      Genitourinary system: E 33%, I 3%, 305 cases. 365 meds
                                      • 10
                                        Nervous system: E 35%, I 2%, 163 cases. 483 meds
                                        • 6
                                          Tests: E 28%, I 1%, 188 cases. 834 meds

                                          Last updated date: 11.02.2024

                                          Instructions
                                          The personalized statistics of Kiberis assesses the importance of symptoms for drugs and the effectiveness of treatment of symptoms and diseases, taking into account the individuality of each patient.
                                          The data is grouped by meaning in the form of a repertory. The atlas displays the most significant organs for this drug.
                                          E - Efficiency. How much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) is negative, because the patient will get worse over time.
                                          I - The effect of the symptom on the overall outcome of the patient's treatment (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
                                          Available only when using PRO account
                                          Content moderator: Vasin A. S.


                                          1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
                                          2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
                                          3. Nothing in the information provided should be interpreted as a call to use these drugs.
                                          4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.